LncTAC Biotechnology Co., Ltd.
PrivateLast Round
Series A
Jun 26, 2026
Total Funding Raised
$44.25M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
LncTAC Biotechnology Co., Ltd. is a biotechnology company that develops lncRNA-based therapeutic drugs and delivery technology platforms for oncology, central nervous system disorders, and dermatology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LncTAC Biotechnology Co., Ltd. Comparables
Compare LncTAC Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 水木星辰生物制药(深圳)有限公司 | 83% | |
| HAYA Therapeutics | 79% | |
| Vivatides Therapeutics | 77% | |
LncTAC Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 26, 2026 | ||||
| VC Round | Oct 26, 2023 |
LncTAC Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lapam Capital | Series A |
| Legend Capital | Series A, VC Round |
| Sunshine Riverhead Capital Investment Management Co., Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2026
$44.25M round led by Lapam Capital.
- Oct 26, 2023
$14M round led by Legend Capital
LncTAC Biotechnology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LncTAC Biotechnology Co., Ltd.'s valuation, stock price, and market status.